TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details






Profile for Lisa Chastain, PHMD

Lisa Chastain

Lisa Chastain, PHMD

  • Associate Professor
  • Assistant Professor of Pharmacy Practice in Ambulatory Care
Office Phone: 214-358-9055
Email: lisa.chastain@ttuhsc.edu
Mail Address: 4500 S Lancaster Rd
Dallas TX 75216-7167

Biography

Dr. Chastain is an Associate Professor in Ambulatory Care at the Texas Tech University HSC School of Pharmacy, Dallas/Fort Worth Campus. Her practice site is at the Fort Worth Outpatient Clinic with the VA North Texas Health Care System (VANTHCS). At her practice site Dr. Chastain focuses care in drug therapy management in the area of diabetes, hypertension, hyperlipidemia and coronary artery disease. Dr. Chastain has twice been awarded as DFW Preceptor of the Year (2008-2009, 2012-2014) by the students of TTUHSC SOP. Most recently Dr. Chastain was recognized by TTUHSC as the 2012 Excellence in Leadership Distinguished Alumni and was a member of the P3 Teaching Team of the Year (2013-2014). Dr. Chastain is the current Residency Program Director for the ASHP-Accredited PGY2 Ambulatory Care Residency at the Dallas/Fort Worth campus.

Research Interests

Diabetes, cardiology, hyperlipidemia, heart failure, angina

Selected Publications:

  • Black R, Higbea A, Duval C, Chastain LM. Pharmacological Management of Obesity in Patients with Type 2 Diabetes. Expert Review of Endocrinology & Metabolism 2016;11(6).
  • Edwards KL, Hadley RL, Baby N, Yeary JC, Chastain LM, Brown C. Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes.. Journal of pharmacy practice 2016.
  • Minze MG, Chastain LM. Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide.. Therapeutics and clinical risk management 2016;12:471-8.
  • Vuylsteke V, Chastain LM, Brown C, Maggu G. Imeglimin: A potential new multi-target drug for Type 2 Diabetes. Drugs in R & D 2015;15(3):227-232.
  • Chastain L, Kildow M, Black R, Kildow C. Type 2 diabetes patients with metformin intolerance. Hospital Pharmacy Europe 2015;77:62-64.
©